Epstein-barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children

Pediatric Dermatology

Volumn 27, Issue 5, 2010, Pages 463-469

  Xu, Zigang ^a   Lian, Shi ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; PREDNISONE; VIRUS DNA; VIRUS RNA;

ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROA VACCINIFORME; HYDROA VACCINIFORME LIKE CUTANEOUS LYMPHOMA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SEROLOGY; SKIN DEFECT; SKIN LYMPHOMA;

ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HAND DERMATOSES; HERPESVIRUS 4, HUMAN; HUMANS; HYDROA VACCINIFORME; LYMPHOMA; MALE; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; VIRAL LOAD;

EID: 77957306867     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2010.01094.x     Document Type: Article

References (20)

1. Goldgeier MH, Nordlund JJ, Lucky AW et al. Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol 1982 118 : 588 591.
2. Sonnex TS, Hawk JL. Hydra vacciniforme: a review of ten cases. Br J Dermatol 1988 118 : 101 108.
3. Iwatsuki K, Satoh M, Yamamoto T et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006 142 : 587 595.
4. Cho KH, Lee SH, Kim CW et al. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol 2004 151 : 372 380.
5. Magana M, Sangueza P, Gil-Beristain J et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutanous T-cell lymphoma. J Am Acad Dermatol 1998 38 : 574 579.
6. Wang PS, Evans AS. Prevalence of antibodies to Epstein-Barr virus and cytomegalovirus in sera from a group of children in the people's republic of China. J Infect Dis 1986 153 : 150 152.
7. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000 343 : 481 492.
8. Kimura H, Hoshino Y, Kanegane H et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001 98 : 280 286.
9. Lu G, Xie Z, Zhao S et al. Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases. Chin Med J 2009 122 : 262 266.
10. Ruiz-Maldonado R, Parrilla FM, Orozco-Covarrubias ML et al. Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol 1995 32 : 37 44.
11. Oono T, Arata J, Masuda T et al. Coexistence of hydroa vacciniforme and malignant lymphoma. Arch Dermatol 1986 122 : 1306 1309.
12. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 3785.
13. Wu YH, Chen HC, Hsiao PF et al. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Int J Dermatol 2007 46 : 1081 1086.
14. Iwatsuki K, Ohtsuka M, Harada H et al. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 1997 133 : 1081 1086.
15. Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol 2002 147 : 587 591.
16. Doeden K, Molina-Kirsch H, Perez E et al. Hydroa-like lymphoma with CD56 expression. J Cutan Pathol 2008 35 : 488 494.
17. Yu JB, Zuo Z, Tang Y et al. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China. Hum Pathol 2009 40 : 807 816.
18. Zhang Y, Nagata H, Ikeuki T et al. Common cytological and cytogenetic features of EBV-positive NK cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 2003 121 : 805 814.
19. Demachi A, Nagata H, Morio T et al. Characterization of Epstein-Barr virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions. Microbiol Immunol 2003 47 : 543 552.
20. Kimura H, Hoshino Y, Hara S et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 2005 191 : 531 539. (Pubitemid 40216668)